APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Drug Delivery Devices

Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance.

Selected research

Industry Research

Implantable Drug Delivery Devices Industry Research Report 2026

1 January 2026126 pages

Choose your research edition.

Industry ResearchImplantable Drug Delivery Devices Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Drug Delivery Devices Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Implantable Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Drug Delivery Devices Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Drug Delivery Devices Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Implantable drug delivery devices are an alternative system that can achieve effective delivery with lower drug concentrations, and as a result, minimise side-effects whilst increasing patient compliance.

BD, B.Braun, AngioDynamics, Smiths Medical and Teleflex, etc. are the leading products in the international market, accounting for 85.5% of the global market.

Report Scope

Read the full market overview

This report quantifies the global Implantable Drug Delivery Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Implantable Drug Delivery Devices Market by Company

BD

B.Braun

AngioDynamics

Smiths Medical

Teleflex

Cook Medical

Fresenius

Vygon

PFM Medical

Districlass

Linhwa

Implantable Drug Delivery Devices Segment by Type

Titanium Drug Delivery System

Plastic Drug Delivery System

Implantable Drug Delivery Devices Segment by Application

Intravenous Chemotherapy

Nutrition Support Therapy

Implantable Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Implantable Drug Delivery Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Implantable Drug Delivery Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Implantable Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Implantable Drug Delivery Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Implantable Drug Delivery Devices Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Implantable Drug Delivery Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Implantable Drug Delivery Devices Revenue of Manufacturers (2021-2026) Table 9. Global Implantable Drug Delivery Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Implantable Drug Delivery Devices Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Implantable Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Implantable Drug Delivery Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Implantable Drug Delivery Devices, Product Type & Application Table 14. Global Implantable Drug Delivery Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Implantable Drug Delivery Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. BD Company Information Table 19. BD Business Overview Table 20. BD Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. BD Implantable Drug Delivery Devices Product Portfolio Table 22. BD Recent Developments Table 23. B.Braun Company Information Table 24. B.Braun Business Overview Table 25. B.Braun Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. B.Braun Implantable Drug Delivery Devices Product Portfolio Table 27. B.Braun Recent Developments Table 28. AngioDynamics Company Information Table 29. AngioDynamics Business Overview Table 30. AngioDynamics Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. AngioDynamics Implantable Drug Delivery Devices Product Portfolio Table 32. AngioDynamics Recent Developments Table 33. Smiths Medical Company Information Table 34. Smiths Medical Business Overview Table 35. Smiths Medical Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Smiths Medical Implantable Drug Delivery Devices Product Portfolio Table 37. Smiths Medical Recent Developments Table 38. Teleflex Company Information Table 39. Teleflex Business Overview Table 40. Teleflex Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Teleflex Implantable Drug Delivery Devices Product Portfolio Table 42. Teleflex Recent Developments Table 43. Cook Medical Company Information Table 44. Cook Medical Business Overview Table 45. Cook Medical Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Cook Medical Implantable Drug Delivery Devices Product Portfolio Table 47. Cook Medical Recent Developments Table 48. Fresenius Company Information Table 49. Fresenius Business Overview Table 50. Fresenius Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Fresenius Implantable Drug Delivery Devices Product Portfolio Table 52. Fresenius Recent Developments Table 53. Vygon Company Information Table 54. Vygon Business Overview Table 55. Vygon Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Vygon Implantable Drug Delivery Devices Product Portfolio Table 57. Vygon Recent Developments Table 58. PFM Medical Company Information Table 59. PFM Medical Business Overview Table 60. PFM Medical Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. PFM Medical Implantable Drug Delivery Devices Product Portfolio Table 62. PFM Medical Recent Developments Table 63. Districlass Company Information Table 64. Districlass Business Overview Table 65. Districlass Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Districlass Implantable Drug Delivery Devices Product Portfolio Table 67. Districlass Recent Developments Table 68. Linhwa Company Information Table 69. Linhwa Business Overview Table 70. Linhwa Implantable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Linhwa Implantable Drug Delivery Devices Product Portfolio Table 72. Linhwa Recent Developments Table 73. Global Implantable Drug Delivery Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Implantable Drug Delivery Devices Sales by Region (2021-2026) & (K Units) Table 75. Global Implantable Drug Delivery Devices Sales Market Share by Region (2021-2026) Table 76. Global Implantable Drug Delivery Devices Sales by Region (2027-2032) & (K Units) Table 77. Global Implantable Drug Delivery Devices Sales Market Share by Region (2027-2032) Table 78. Global Implantable Drug Delivery Devices Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Implantable Drug Delivery Devices Revenue Market Share by Region (2021-2026) Table 80. Global Implantable Drug Delivery Devices Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Implantable Drug Delivery Devices Revenue Market Share by Region (2027-2032) Table 82. North America Implantable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Implantable Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 84. North America Implantable Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 85. North America Implantable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Implantable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Implantable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Implantable Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 89. Europe Implantable Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 90. Europe Implantable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Implantable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Implantable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Implantable Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Implantable Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Implantable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Implantable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Implantable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Implantable Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 99. South America Implantable Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 100. South America Implantable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Implantable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Implantable Drug Delivery Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Implantable Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Implantable Drug Delivery Devices Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Implantable Drug Delivery Devices Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Implantable Drug Delivery Devices Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Implantable Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 108. Global Implantable Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 109. Global Implantable Drug Delivery Devices Sales Market Share by Type (2021-2026) Table 110. Global Implantable Drug Delivery Devices Sales Market Share by Type (2027-2032) Table 111. Global Implantable Drug Delivery Devices Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Implantable Drug Delivery Devices Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Implantable Drug Delivery Devices Revenue Market Share by Type (2021-2026) Table 114. Global Implantable Drug Delivery Devices Revenue Market Share by Type (2027-2032) Table 115. Global Implantable Drug Delivery Devices Price by Type (2021-2026) & (US$/Unit) Table 116. Global Implantable Drug Delivery Devices Price by Type (2027-2032) & (US$/Unit) Table 117. Global Implantable Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 118. Global Implantable Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 119. Global Implantable Drug Delivery Devices Sales Market Share by Application (2021-2026) Table 120. Global Implantable Drug Delivery Devices Sales Market Share by Application (2027-2032) Table 121. Global Implantable Drug Delivery Devices Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Implantable Drug Delivery Devices Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Implantable Drug Delivery Devices Revenue Market Share by Application (2021-2026) Table 124. Global Implantable Drug Delivery Devices Revenue Market Share by Application (2027-2032) Table 125. Global Implantable Drug Delivery Devices Price by Application (2021-2026) & (US$/Unit) Table 126. Global Implantable Drug Delivery Devices Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Implantable Drug Delivery Devices Distributors List Table 130. Implantable Drug Delivery Devices Customers List Table 131. Implantable Drug Delivery Devices Industry Trends Table 132. Implantable Drug Delivery Devices Industry Drivers Table 133. Implantable Drug Delivery Devices Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Implantable Drug Delivery Devices Product Image Figure 5. Global Implantable Drug Delivery Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Implantable Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Implantable Drug Delivery Devices Sales (2021-2032) & (K Units) Figure 8. Global Implantable Drug Delivery Devices Average Price (US$/Unit) & (2021-2032) Figure 9. Titanium Drug Delivery System Product Image Figure 10. Plastic Drug Delivery System Product Image Figure 11. Intravenous Chemotherapy Product Image Figure 12. Nutrition Support Therapy Product Image Figure 13. Global Implantable Drug Delivery Devices Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Implantable Drug Delivery Devices, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Implantable Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Implantable Drug Delivery Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Implantable Drug Delivery Devices Sales by Region in 2025 Figure 19. Global Implantable Drug Delivery Devices Revenue by Region in 2025 Figure 20. North America Implantable Drug Delivery Devices Market Size by Country in 2025 Figure 21. North America Implantable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 22. North America Implantable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 23. United States Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Implantable Drug Delivery Devices Market Size by Country in 2025 Figure 27. Europe Implantable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 28. Europe Implantable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 29. Germany Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Implantable Drug Delivery Devices Market Size by Country in 2025 Figure 40. Asia Pacific Implantable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Implantable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 42. China Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Implantable Drug Delivery Devices Market Size by Country in 2025 Figure 51. South America Implantable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 52. South America Implantable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 53. Brazil Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Implantable Drug Delivery Devices Market Size by Country in 2025 Figure 57. Middle East and Africa Implantable Drug Delivery Devices Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Implantable Drug Delivery Devices Revenue Market Share by Country (2021-2032) Figure 59. Egypt Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Implantable Drug Delivery Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Implantable Drug Delivery Devices Sales Market Share by Type (2021-2032) Figure 65. Global Implantable Drug Delivery Devices Revenue Market Share by Type (2021-2032) Figure 66. Global Implantable Drug Delivery Devices Price (US$/Unit) by Type (2021-2032) Figure 67. Global Implantable Drug Delivery Devices Sales Market Share by Application (2021-2032) Figure 68. Global Implantable Drug Delivery Devices Revenue Market Share by Application (2021-2032) Figure 69. Global Implantable Drug Delivery Devices Price (US$/Unit) by Application (2021-2032) Figure 70. Implantable Drug Delivery Devices Value Chain Figure 71. Implantable Drug Delivery Devices Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Implantable Drug Delivery Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Titanium Drug Delivery System
  • Plastic Drug Delivery System
Applications
  • Intravenous Chemotherapy
  • Nutrition Support Therapy
Companies covered
  • BD
  • B.Braun
  • AngioDynamics
  • Smiths Medical
  • Teleflex
  • Cook Medical
  • Fresenius
  • Vygon
  • PFM Medical
  • Districlass
  • Linhwa

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Implantable Drug Delivery Devices Market Size (2021-2032)
  4. 2.2.2 Global Implantable Drug Delivery Devices Sales (2021-2032)
  5. 2.2.3 Global Implantable Drug Delivery Devices Market Average Price (2021-2032)
  6. 2.3 Implantable Drug Delivery Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Titanium Drug Delivery System
  9. 2.3.3 Plastic Drug Delivery System
  10. 2.4 Implantable Drug Delivery Devices by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Intravenous Chemotherapy
  13. 2.4.3 Nutrition Support Therapy
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Implantable Drug Delivery Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Implantable Drug Delivery Devices Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Implantable Drug Delivery Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Implantable Drug Delivery Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Implantable Drug Delivery Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Implantable Drug Delivery Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Implantable Drug Delivery Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Implantable Drug Delivery Devices, Established Date
  9. 3.9 Global Implantable Drug Delivery Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 BD
  2. 4.1.1 BD Company Information
  3. 4.1.2 BD Business Overview
  4. 4.1.3 BD Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 BD Implantable Drug Delivery Devices Product Portfolio
  6. 4.1.5 BD Recent Developments
  7. 4.2 B.Braun
  8. 4.2.1 B.Braun Company Information
  9. 4.2.2 B.Braun Business Overview
  10. 4.2.3 B.Braun Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 B.Braun Implantable Drug Delivery Devices Product Portfolio
  12. 4.2.5 B.Braun Recent Developments
  13. 4.3 AngioDynamics
  14. 4.3.1 AngioDynamics Company Information
  15. 4.3.2 AngioDynamics Business Overview
  16. 4.3.3 AngioDynamics Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AngioDynamics Implantable Drug Delivery Devices Product Portfolio
  18. 4.3.5 AngioDynamics Recent Developments
  19. 4.4 Smiths Medical
  20. 4.4.1 Smiths Medical Company Information
  21. 4.4.2 Smiths Medical Business Overview
  22. 4.4.3 Smiths Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Smiths Medical Implantable Drug Delivery Devices Product Portfolio
  24. 4.4.5 Smiths Medical Recent Developments
  25. 4.5 Teleflex
  26. 4.5.1 Teleflex Company Information
  27. 4.5.2 Teleflex Business Overview
  28. 4.5.3 Teleflex Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Teleflex Implantable Drug Delivery Devices Product Portfolio
  30. 4.5.5 Teleflex Recent Developments
  31. 4.6 Cook Medical
  32. 4.6.1 Cook Medical Company Information
  33. 4.6.2 Cook Medical Business Overview
  34. 4.6.3 Cook Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Cook Medical Implantable Drug Delivery Devices Product Portfolio
  36. 4.6.5 Cook Medical Recent Developments
  37. 4.7 Fresenius
  38. 4.7.1 Fresenius Company Information
  39. 4.7.2 Fresenius Business Overview
  40. 4.7.3 Fresenius Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Fresenius Implantable Drug Delivery Devices Product Portfolio
  42. 4.7.5 Fresenius Recent Developments
  43. 4.8 Vygon
  44. 4.8.1 Vygon Company Information
  45. 4.8.2 Vygon Business Overview
  46. 4.8.3 Vygon Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Vygon Implantable Drug Delivery Devices Product Portfolio
  48. 4.8.5 Vygon Recent Developments
  49. 4.9 PFM Medical
  50. 4.9.1 PFM Medical Company Information
  51. 4.9.2 PFM Medical Business Overview
  52. 4.9.3 PFM Medical Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 PFM Medical Implantable Drug Delivery Devices Product Portfolio
  54. 4.9.5 PFM Medical Recent Developments
  55. 4.10 Districlass
  56. 4.10.1 Districlass Company Information
  57. 4.10.2 Districlass Business Overview
  58. 4.10.3 Districlass Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Districlass Implantable Drug Delivery Devices Product Portfolio
  60. 4.10.5 Districlass Recent Developments
  61. 4.11 Linhwa
  62. 4.11.1 Linhwa Company Information
  63. 4.11.2 Linhwa Business Overview
  64. 4.11.3 Linhwa Implantable Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Linhwa Implantable Drug Delivery Devices Product Portfolio
  66. 4.11.5 Linhwa Recent Developments
5 Global Implantable Drug Delivery Devices Market Scenario by Region
  1. 5.1 Global Implantable Drug Delivery Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Implantable Drug Delivery Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Implantable Drug Delivery Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Implantable Drug Delivery Devices Sales by Region: 2027-2032
  5. 5.3 Global Implantable Drug Delivery Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Implantable Drug Delivery Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Implantable Drug Delivery Devices Revenue by Region: 2027-2032
  8. 5.4 North America Implantable Drug Delivery Devices Market Facts & Figures by Country
  9. 5.4.1 North America Implantable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Implantable Drug Delivery Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Implantable Drug Delivery Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Implantable Drug Delivery Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Implantable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Implantable Drug Delivery Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Implantable Drug Delivery Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Implantable Drug Delivery Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Implantable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Implantable Drug Delivery Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Implantable Drug Delivery Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Implantable Drug Delivery Devices Market Facts & Figures by Country
  41. 5.7.1 South America Implantable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Implantable Drug Delivery Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Implantable Drug Delivery Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Implantable Drug Delivery Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Implantable Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Implantable Drug Delivery Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Implantable Drug Delivery Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Implantable Drug Delivery Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Implantable Drug Delivery Devices Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Implantable Drug Delivery Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Implantable Drug Delivery Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Implantable Drug Delivery Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Implantable Drug Delivery Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Implantable Drug Delivery Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Implantable Drug Delivery Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Implantable Drug Delivery Devices Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Implantable Drug Delivery Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Implantable Drug Delivery Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Implantable Drug Delivery Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Implantable Drug Delivery Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Implantable Drug Delivery Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Implantable Drug Delivery Devices Value Chain Analysis
  2. 8.1.1 Implantable Drug Delivery Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Implantable Drug Delivery Devices Production Mode & Process
  5. 8.2 Implantable Drug Delivery Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Implantable Drug Delivery Devices Distributors
  8. 8.2.3 Implantable Drug Delivery Devices Customers
9 Global Implantable Drug Delivery Devices Analyzing Market Dynamics
  1. 9.1 Implantable Drug Delivery Devices Industry Trends
  2. 9.2 Implantable Drug Delivery Devices Industry Drivers
  3. 9.3 Implantable Drug Delivery Devices Industry Opportunities and Challenges
  4. 9.4 Implantable Drug Delivery Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst